Progenity to Participate in the Raymond James 2021 Human Health Innovation Conference

Rhea-AI Summary

Progenity, Inc. (Nasdaq: PROG) announced that CEO Harry Stylli will participate in a fireside chat at the virtual Raymond James 2021 Human Health Innovation Conference on June 22, 2021, at 10:40 a.m. ET. The event will be accessible via a live webcast on the company's investor relations webpage. Progenity, a biotech company, focuses on gastrointestinal health and oral biotherapeutics, utilizing a multi-omics approach to enhance diagnostics and targeted therapies for better patient outcomes.

SAN DIEGO, June 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that Harry Stylli, PhD, CEO, chairman of the board, and co-founder of Progenity, will participate in a fireside chat at the virtual Raymond James 2021 Human Health Innovation Conference at 10:40 a.m. ET / 7:40 a.m. PT on Tuesday, June 22, 2021.

A live webcast and archive of the fireside chat will be available online from the investor relations section of the company website at www.progenity.com.

About Progenity

Progenity, Inc. is a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics. Progenity applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.

For more information about Progenity’s products and pipeline visit www.progenity.com, or follow the company on LinkedIn or Twitter.

Investor Contact:
Robert Uhl
Managing Director, Westwicke ICR
ir@progenity.com
(619) 228-5886

Media Contact:
Kate Blom-Lowery
CG Life
media@progenity.com
(858) 457-2436

FAQ

What event will Progenity participate in on June 22, 2021?

Progenity will participate in the virtual Raymond James 2021 Human Health Innovation Conference.

Who will represent Progenity at the Raymond James conference?

CEO Harry Stylli will represent Progenity during the fireside chat.

What time is Progenity's presentation at the conference?

Progenity's fireside chat is scheduled for 10:40 a.m. ET on June 22, 2021.

How can I watch Progenity's presentation live?

The presentation can be accessed via a live webcast on Progenity's investor relations section of their website.

What is Progenity's focus in biotechnology?

Progenity focuses on gastrointestinal health and oral biotherapeutics using a multi-omics approach.